Correlation Between Novartis and Scilex Holding

Can any of the company-specific risk be diversified away by investing in both Novartis and Scilex Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Scilex Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novartis AG and Scilex Holding, you can compare the effects of market volatilities on Novartis and Scilex Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Scilex Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Scilex Holding.

Diversification Opportunities for Novartis and Scilex Holding

0.88

Correlation Coefficient

Novartis  Scilex Holding

Very poor diversification

The 3 months correlation between Novartis and Scilex is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Scilex Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scilex Holding and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Scilex Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scilex Holding has no effect on the direction of Novartis i.e., Novartis and Scilex Holding go up and down completely randomly.

Pair Corralation between Novartis and Scilex Holding

Assuming the 90 days horizon Novartis AG is expected to generate 0.24 times more return on investment than Scilex Holding. However, Novartis AG is 4.09 times less risky than Scilex Holding. It trades about 0.09 of its potential returns per unit of risk. Scilex Holding is currently generating about -0.27 per unit of risk. If you would invest  9,875  in Novartis AG on October 10, 2024 and sell it today you would earn a total of  280.00  from holding Novartis AG or generate 2.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Novartis AG  vs.  Scilex Holding

Novartis AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Novartis is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Scilex Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scilex Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Novartis and Scilex Holding

The main advantage of trading using opposite Novartis and Scilex Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Scilex Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scilex Holding will offset losses from the drop in Scilex Holding's long position.

The idea behind Novartis AG and Scilex Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.